BioTek Expands in the United Kingdom
News Jun 05, 2015
BioTek Instruments, Inc. expands their ongoing investment in the European microplate-based technology market with the opening of their new UK Office in Swindon. Mr. Dominic Herring, previously BioTek’s Business and Development Manager with BioTek Singapore, was named General Manager. The new office will focus on bringing enhanced applications and technical support to current and future customers in the United Kingdom.
"The UK’s biotechnology and life scientific sectors are growing; supported by the government’s focus and investment," noted Dominic Herring, BioTek’s UK General Manager. "Our new and expanded direct office in Swindon will allow us to provide local, comprehensive and immediate sales, applications and service support to our rapidly increasing customer base in a market that continues to demonstrate high quality scientific research." BioTek UK is now fully functional and will house administration, sales, service, technical support, training and a complete supplies inventory.
"The establishment of our new BioTek UK Office will allow BioTek to increase our presence in this very important marketplace," commented Briar Alpert, BioTek President and CEO. "In addition to providing local service and applications support, our customers in the UK will have direct access to the company's global scientific and applications resources. Ultimately, this will lead to enhanced satisfaction for our customers."
Researchers Awarded $28M for Illuminating Druggable Genome NIH GrantsNews
Researchers receive grants as part of the NIH program focused on experimental and informatics approaches to characterize understudied proteins from three gene families: ion channels, G protein-coupled receptors (GPCRs), and protein kinases.READ MORE
PhoreMost Completes $15M (£11M) Series-A Round to Enter Drug DiscoveryNews
Investment to fund expansion of operations and progression of drug target pipeline.READ MORE
Targeting a Leaky Protein that Causes ParalysisNews
A rare genetic disorder in which people are overcome suddenly with profound muscle weakness is caused by a hole in a membrane protein that allows sodium ions to leak across cell membranes. Compounds containing a chemical group called guanidinium can block the pore created by the mutation and stop the sodium leak without altering the voltage sensor’s ability to function.READ MORE
Comments | 0 ADD COMMENT
9th International Conference on Mass Spectrometry and Chromatography
Sep 21 - Sep 22, 2018